Browsing by Subject
Ara mostrant els elements 21-40 d 372
-
Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials
(Nature Research, 2022-05-24) -
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial
(Wolters Kluwer Health, 2021-08) -
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
(American Society of Clinical Oncology, 2023-04-10) -
Advances in the systemic treatment of therapeutic approaches in biliary tract cancer
(Elsevier, 2022-06) -
Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database
(Frontiers Media, 2023-01-18) -
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
(American Association for Cancer Research, 2022-07-01) -
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer
(American Association for Cancer Research, 2023-06-15)